The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
NEJM study shows strong protection across strains
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
This is an exciting and meaningful milestone for GRIN Therapeutics
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Subscribe To Our Newsletter & Stay Updated
